Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Orionis Biosciences Inc

Clinical trials sponsored by Orionis Biosciences Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug ORB-021 enters early human testing for advanced cancers Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

New drug ORB-021 enters early human testing for advanced cancers

Disease control Recruiting now

This early-phase trial is testing whether a new drug called ORB-021 is safe and tolerable for people with advanced solid tumors who have no standard treatment options left. About 36 adults will receive the drug through an IV to find the best dose for future studies. The main goal…

Phase 1 • Sponsor: Orionis Biosciences Inc • Aim: Disease control

Last updated Aug 28, 2026 00:00 UTC